Biotech Financing Roundup: Jade Bio’s Launch, Brenig’s Debut, Confo’s Cash & More

A spate of biotech and healthcare start-ups have received funding for their work treating various medical conditions. Notable announcements include Paragon Therapeutics’ biotech Jade Biosciences receiving $80m in financing; artificial intelligence-driven platform firm Abiologics securing $50m; GRO Biosciences’s receipt of $60m towards bring its gout drug candidate to clinical trials, and immunology and cancer company Third Arc Bio confirming a $165m investment.